Product Program year 2025 Source: CMS Open Payments

Vigafyde

Drug Neurology

NDC 80789-003-15

Open in the dashboard

General payments

$12,299

440 payments

Research payments

$0

0 payments

Through program year 2025, $12,299 in general payments and $0 in research payments were reported against Vigafyde (Neurology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2025 General $12,299 440

Breakdown

Who paid General payments · program year 2025
  1. Upsher-Smith Laboratories LLC $12,299 440 payments
Top recipients General payments · program year 2025
  1. Katherine Labiner Epilepsy · Austin, TX $346 3% · 9 payments
  2. Daniel Gustkey Epilepsy · Austin, TX $276 2% · 7 payments
  3. Holly Keeley Neurology with Special Qualifications in Child Neurology · Austin, TX $272 2% · 7 payments
  4. Karen Keough Epilepsy · Austin, TX $222 2% · 6 payments
  5. Paul Maertens Neurology with Special Qualifications in Child Neurology · Mobile, AL $211 2% · 5 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Neurology with Special Qualifications in Child Neurology Psychiatry & Neurology $4,736 40% · 113 practitioners
  2. Epilepsy Psychiatry & Neurology $1,150 10% · 12 practitioners
  3. Nurse Practitioner, Family Nurse Practitioner $1,093 9% · 25 practitioners
  4. Nurse Practitioner, Pediatrics Nurse Practitioner $1,086 9% · 27 practitioners
  5. Nurse Practitioner $936 8% · 20 practitioners

The top 5 of 24 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Texas $2,741 22% · 32 recipients
  2. Florida $1,945 16% · 50 recipients
  3. California $1,599 13% · 40 recipients
  4. Tennessee $1,248 10% · 30 recipients
  5. Michigan $1,052 9% · 34 recipients

The top 5 of 27 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

440 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record